logo
    A review of feline leukemia virus and feline immunodeficiency virus seroprevalence in cats in Canada
    27
    Citation
    11
    Reference
    10
    Related Paper
    Citation Trend
    Keywords:
    Feline leukemia virus
    Feline immunodeficiency virus
    Seroprevalence
    Feline immunodeficiency virus (FIV) seroprevalence is evaluated in 3 groups of cats. Seventy-four unowned urban strays were tested, as well as 20 cats from a small feral cat colony, and 152 client-owned cats. Of the 246 cats tested, 161 (65%) were male and 85 (35%) were female. Seroprevalence for FIV was 23% in the urban strays, 5% in the feral cat colony, and 5.9% in the client-owned cats. Ten cats (4%) were also positive for Feline leukemia virus (FeLV) antigen, including 2 cats coinfected with FeLV and FIV. Seroprevalence for FIV in cats from Ottawa is similar to that found in other nonrandom studies of cats in North America.
    Feline immunodeficiency virus
    Feline leukemia virus
    Seroprevalence
    Feral cat
    Feline calicivirus
    Citations (40)
    Approximately 5% of cats in animal shelters in the United States test positive for either feline leukemia virus (FeLV) or feline immunodeficiency virus (FIV), which translates to more than 100,000 positive cats managed by shelters each year. Little is known about the current status of retroviral management in animal shelters, particularly in regions burdened by chronic pet overpopulation and high shelter admissions, such as the southern United States. The purpose of this study was to describe feline retroviral management in Florida shelters. Shelters were surveyed on practices including selection of cats for testing, diagnostic techniques, and outcome options for cats with positive test results. Responses were received from 139 of 153 animal shelters known to admit cats, including 55 municipal shelters (40%), 70 private shelters (50%), and 14 private shelters with municipal contracts (10%). A total of 115 shelters (83%) performed at least some testing, most using combination point-of-care devices for simultaneous FeLV antigen and FIV antibody screening. Of shelters that performed any testing, 56 (49%) tested all cats for FeLV and 52 (45%) tested all cats for both FeLV and FIV. The most common reason for testing was screening adoptable cats (108 shelters; 94%) and cats available for transfer to other organizations (78; 68%). Testing cats in trap-neuter-return/return-to-field programs was least common (21; 18%). Most common outcome options for positive cats included adoption (74; 64%), transfer (62; 54%), and euthanasia (49; 43%). Euthanasia following a positive test result was more common for cats with FeLV (49; 43%) than for cats with FIV (29; 25%) and was more common in municipal shelters, rural shelters, shelters taking in <500 cats a year, and shelters with overall live outcome rates for cats <70%. Although Florida shelter compliance with national guidelines for identification and management of FeLV and FIV positive cats was variable, most had live outcome options for at least some of their cats with positive test results. Increased access to training and practical programmatic tools may help more shelters implement cost-effective testing protocols, reduce risk for transmission to other cats, and support the best outcomes for this vulnerable population of cats.
    Feline immunodeficiency virus
    Feline leukemia virus
    Feline calicivirus
    Companion animal
    Our aims were to determine the frequencies of feline immunodeficiency virus (FIV) and feline leukemia virus (FeLV) in owned and stray cats in the northeastern region of Brazil, ascertain the status of FeLV infection, and investigate potential associated factors among the owned cats.Blood samples from 200 asymptomatic owned cats and 30 stray cats were processed using nested PCR and commercial immunochromatographic tests to diagnose infections.To evaluate the factors associated with FIV and/or FeLV in owned cats, a semistructured interview was conducted with each owner about the animal's environment, and these data were subjected to unconditional logistic regression.The frequencies for owned cats were 6% (12/200) and 3% (6/200) for FIV and FeLV, respectively.No owned cat was positive for both viruses.Stray cats showed frequencies of 6.66% (2/30) and 0% (0/30) for FIV and FeLV, respectively.Contact with other cats and living in peri-urban areas were considered to be risk factors (P < 0.05) for FIV.We did not identify any factors associated with infections with L.C. Lacerda et al. Genetics and Molecular Research 16 (2): gmr16029633FeLV.Our results confirm the presence of these two retroviruses in the region under study.Our use of different diagnostic techniques allowed us to determine the frequency of retroviruses in the feline population more accurately, particularly with regard to infections by FeLV, which have complex pathogenesis.
    Feline leukemia virus
    Feline immunodeficiency virus
    Citations (33)
    In a nationwide study 6101 cats were tested for presence of feline leukemia virus (FeLV) antigen and for feline immunodeficiency virus (FIV) antibodies utilizing enzyme linked immunosorbent assay (ELISA). 21.8% of the German cat population may be FeLV- and/or FIV-positive. Of the animals tested, 13.4% were found to be FeLV carriers, while 8.4% showed evidence of FIV infection. Infection with both viruses was identified in 2.1% of the cats tested. Of the animals showing clinical symptoms, nearly one cat in three was found to be carrying either one or both of the viruses. Male cats were more likely to be infected then were females, similarly as were free-roaming cats, compared with confined cats; domestic cats, compared with purebred cats; and cats > 6 years old, compared with younger cats.
    Feline immunodeficiency virus
    Feline leukemia virus
    Purebred
    Citations (23)
    This study was conducted to determine prevalence and risk factors for retrovirus infection of infected cats in a large cat population in Germany by evaluation of 17,462 client-owned cats that were tested for the presence of feline immunodeficiency virus (FIV) antibodies or feline leukaemia virus (FeLV) antigen. The owners of a subset of 100 cats were contacted to determine their cat's survival times. Prevalence of FIV and FeLV was 3.2% and 3.6%, respectively, remaining stable for FIV, but decreasing for FeLV (6-1%) over 10 years. Median age was 6 years in FIV- and 3 years in FeLV-infected cats. Risk factors for FIV infection were male gender, older age, mixed breed, access to outdoor, aggressive behaviour, and FeLV co-infection; and for FeLV infection contact to other cats, aggressive behaviour, and FIV co-infection. Median survival time of FIV-infected cats was not significantly different to non-infected cats, whereas FeLV-infected cats had significantly shorter median survival times than non-infected cats.
    Feline immunodeficiency virus
    Feline leukemia virus
    Citations (159)
    A representative sample of the pet cat population of the United Kingdom was surveyed. Blood samples from 1204 sick and 1007 healthy cats of known breed, age and sex were tested for antibodies to feline immunodeficiency virus (FIV) and feline leukaemia virus (FeLV). The prevalence of FIV was 19 per cent in sick cats and 6 per cent in healthy cats, and the prevalence of FeLV was 18 per cent in sick cats and 5 per cent in healthy cats; both infections were more common in domestic cats than in pedigree cats. Feline immunodeficiency virus was more prevalent in older cats but FeLV was more prevalent in younger cats. There was no difference between the prevalence of FeLV in male and female cats but male cats were more likely to be infected with FIV than female cats. No interaction was demonstrated between FIV and FeLV infections. Of the cats which were in contact with FIV in households with more than one cat, 21 per cent had seroconverted. The prevalence of FeLV viraemia in cats in contact with FeLV was 14 per cent. The clinical signs associated with FIV were pyrexia, gingivitis/stomatitis and respiratory signs, and with FeLV, pyrexia and anaemia. It was concluded that both viruses were significant causes of disease, and that the cats most likely to be infected with FIV were older, free-roaming male cats and for FeLV, younger, free-roaming cats.
    Feline immunodeficiency virus
    Feline leukemia virus
    Citations (166)
    A new program to address the feral cat population on Prince Edward Island was undertaken during the spring and summer of 2001. Feral cats from specific geographic areas were trapped, sedated, and tested for feline leukemia virus and feline immunodeficiency virus. Healthy cats were neutered, dewermed, vaccinated, tattooed, and released to their area of origin. A total of 185 cats and kittens were trapped and tested during a 14-week period; 158 cats and kittens as young as 6 weeks of age were neutered and released. Twenty-three adult cats were positive for feline leukemia virus, feline immunodeficiency virus, or both, and were euthanized.
    Feline immunodeficiency virus
    Feline leukemia virus
    Feral cat
    Citations (45)
    The seroprevalence of feline immunodeficiency virus ( FIV ) in 203 apparently healthy domestic cats living in the district of Pisa, central Italy, was 11·3 per cent, and the prevalence of feline leukaemia virus ( FeLV ) was 8·4 per cent. The prevalence of FIV depended significantly on the lifestyle and age of the cats; cats living outdoors were more likely to be FIV ‐positive than cats living indoors, and the proportion of FIV ‐positive cats increased with age. In contrast, there was no significant relationship between these variables and the prevalence of FeLV . There was no significant relationship between the cats’ seropositivity for FIV and FeLV . The results of a five‐year field study to control FeLV infection by vaccination in a colony of 30 domestic adult cats naturally exposed to the infection suggest that the vaccination was effective in FIV ‐negative cats, but failed to protect FIV ‐positive cats against FeLV .
    Feline immunodeficiency virus
    Feline leukemia virus
    Seroprevalence
    Citations (48)
    Feline leukemia virus
    Neoplastic disease
    Feline immunodeficiency virus